Charles River Laboratories (CRL)

Deferred Revenue

$203.04M

Quarterly · Period ending: · USD

CRL logo

CRL Deferred Revenue

Latest reported$203.04M
CRL Quarterly Deferred Revenue ($0.00 → $203.04M)
High-resolution chart · PNG

CRL deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Charles River Laboratories Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
203,035,000
194,330,000
210,418,000
237,728,000
268,340,000
250,462,000
248,322,000
251,968,000
247,177,000
256,383,000
241,820,000
320,332,000
334,818,000
355,588,000
264,259,000
328,377,000
242,084,000
292,245,000
219,703,000
270,264,000
276,310,000
249,684,000
250,186,000
215,326,000
211,575,000
216,148,000
204,885,000
202,101,000
200,453,000
170,266,000
145,139,000
185,346,000
167,936,000
122,039,000
117,569,000
108,984,000
119,336,000
127,591,000
127,731,000
119,298,000
118,837,000
80,297,000
81,343,000
76,019,000
77,382,000
76,658,000
78,124,000
66,920,000
61,870,000
54,422,000
54,177,000
55,357,000
53,695,000
53,187,000
56,422,000
57,833,000
60,993,000
58,195,000
56,530,000
54,570,000
59,045,000
58,832,000
66,905,000
62,145,000
61,651,000
67,813,000
72,390,000
73,416,000
74,930,000
83,689,000
86,707,000
85,470,000
94,889,000
97,556,000
102,021,000
88,447,000
94,963,000
88,526,000
93,197,000
78,941,000
82,352,000
100,379,000
116,302,000
97,345,000
103,850,000
108,456,000
117,490,000
37,321,000
33,603,000
33,099,000
30,846,000
25,248,000
24,997,000
23,629,000
27,029,000
22,062,000
22,168,000
23,160,000
22,210,000
16,786,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.